Cambridge Investment Research Advisors, Inc. United Therapeutics Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 11,176 shares of UTHR stock, worth $4.17 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,176
Previous 2,587
332.01%
Holding current value
$4.17 Million
Previous $824,000
386.04%
% of portfolio
0.01%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding UTHR
# of Institutions
669Shares Held
42.8MCall Options Held
194KPut Options Held
295K-
Black Rock Inc. New York, NY5.47MShares$2.04 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.64 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.18 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.07 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$835 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $17B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...